Figure 3.
Potential biomarkers for mitochondrial dysfunction in PD fall into several categories based on biological function. Biomarkers may be useful for patient stratification (red), measuring therapeutic efficacy (yellow) or potentially both. Biomarkers are organized based on increasing levels of supporting evidence.